vs

Side-by-side financial comparison of DHT Holdings, Inc. (DHT) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

DHT Holdings, Inc. is the larger business by last-quarter revenue ($107.3M vs $76.2M, roughly 1.4× VIEMED HEALTHCARE, INC.). DHT Holdings, Inc. runs the higher net margin — 41.7% vs 7.4%, a 34.3% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -24.5%).

DHT Holdings, Inc. is an independent international crude oil tanker operator that owns and manages a fleet of very large crude carriers. It offers marine transportation services for crude oil across major global trade routes, serving clients including leading oil producers, refineries, and commodity trading enterprises worldwide.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

DHT vs VMD — Head-to-Head

Bigger by revenue
DHT
DHT
1.4× larger
DHT
$107.3M
$76.2M
VMD
Growing faster (revenue YoY)
VMD
VMD
+50.0% gap
VMD
25.5%
-24.5%
DHT
Higher net margin
DHT
DHT
34.3% more per $
DHT
41.7%
7.4%
VMD

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DHT
DHT
VMD
VMD
Revenue
$107.3M
$76.2M
Net Profit
$44.8M
$5.6M
Gross Margin
57.9%
Operating Margin
44.2%
11.0%
Net Margin
41.7%
7.4%
Revenue YoY
-24.5%
25.5%
Net Profit YoY
27.3%
30.7%
EPS (diluted)
$0.28
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHT
DHT
VMD
VMD
Q4 25
$76.2M
Q3 25
$107.3M
$71.9M
Q2 25
$63.1M
Q1 25
$59.1M
Q4 24
$60.7M
Q3 24
$142.1M
$58.0M
Q2 24
$55.0M
Q1 24
$50.6M
Net Profit
DHT
DHT
VMD
VMD
Q4 25
$5.6M
Q3 25
$44.8M
$3.5M
Q2 25
$3.2M
Q1 25
$2.6M
Q4 24
$4.3M
Q3 24
$35.2M
$3.9M
Q2 24
$1.5M
Q1 24
$1.6M
Gross Margin
DHT
DHT
VMD
VMD
Q4 25
57.9%
Q3 25
57.5%
Q2 25
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
59.8%
Q1 24
58.9%
Operating Margin
DHT
DHT
VMD
VMD
Q4 25
11.0%
Q3 25
44.2%
7.8%
Q2 25
8.1%
Q1 25
6.5%
Q4 24
10.6%
Q3 24
29.7%
9.7%
Q2 24
6.6%
Q1 24
4.4%
Net Margin
DHT
DHT
VMD
VMD
Q4 25
7.4%
Q3 25
41.7%
4.9%
Q2 25
5.0%
Q1 25
4.4%
Q4 24
7.1%
Q3 24
24.8%
6.7%
Q2 24
2.7%
Q1 24
3.2%
EPS (diluted)
DHT
DHT
VMD
VMD
Q4 25
$0.14
Q3 25
$0.28
$0.09
Q2 25
$0.08
Q1 25
$0.06
Q4 24
$0.10
Q3 24
$0.22
$0.10
Q2 24
$0.04
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHT
DHT
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$81.3M
$13.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.1B
$141.5M
Total Assets
$1.4B
$199.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHT
DHT
VMD
VMD
Q4 25
$13.5M
Q3 25
$81.3M
$11.1M
Q2 25
$20.0M
Q1 25
$10.2M
Q4 24
$17.5M
Q3 24
$73.8M
$11.3M
Q2 24
$8.8M
Q1 24
$7.3M
Stockholders' Equity
DHT
DHT
VMD
VMD
Q4 25
$141.5M
Q3 25
$1.1B
$133.6M
Q2 25
$139.7M
Q1 25
$134.8M
Q4 24
$131.4M
Q3 24
$1.0B
$125.0M
Q2 24
$119.4M
Q1 24
$116.3M
Total Assets
DHT
DHT
VMD
VMD
Q4 25
$199.2M
Q3 25
$1.4B
$202.4M
Q2 25
$184.6M
Q1 25
$178.1M
Q4 24
$177.1M
Q3 24
$1.5B
$169.5M
Q2 24
$163.9M
Q1 24
$154.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHT
DHT
VMD
VMD
Operating Cash FlowLast quarter
$60.9M
$18.4M
Free Cash FlowOCF − Capex
$9.7M
FCF MarginFCF / Revenue
12.7%
Capex IntensityCapex / Revenue
11.5%
Cash ConversionOCF / Net Profit
1.36×
3.27×
TTM Free Cash FlowTrailing 4 quarters
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHT
DHT
VMD
VMD
Q4 25
$18.4M
Q3 25
$60.9M
$18.4M
Q2 25
$12.3M
Q1 25
$2.9M
Q4 24
$15.0M
Q3 24
$80.1M
$12.7M
Q2 24
$10.2M
Q1 24
$1.2M
Free Cash Flow
DHT
DHT
VMD
VMD
Q4 25
$9.7M
Q3 25
$10.7M
Q2 25
$4.1M
Q1 25
$-12.6M
Q4 24
$3.2M
Q3 24
$1.7M
Q2 24
$1.2M
Q1 24
$-4.8M
FCF Margin
DHT
DHT
VMD
VMD
Q4 25
12.7%
Q3 25
14.9%
Q2 25
6.5%
Q1 25
-21.4%
Q4 24
5.2%
Q3 24
3.0%
Q2 24
2.3%
Q1 24
-9.5%
Capex Intensity
DHT
DHT
VMD
VMD
Q4 25
11.5%
Q3 25
10.6%
Q2 25
12.9%
Q1 25
26.2%
Q4 24
19.5%
Q3 24
19.0%
Q2 24
16.3%
Q1 24
11.9%
Cash Conversion
DHT
DHT
VMD
VMD
Q4 25
3.27×
Q3 25
1.36×
5.23×
Q2 25
3.88×
Q1 25
1.09×
Q4 24
3.47×
Q3 24
2.28×
3.29×
Q2 24
6.94×
Q1 24
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons